USA - NYSE:RF - US7591EP1005 - Common Stock
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.42B | 7.08B | 7.58B | 7.21B | 6.44B | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 4.94B | 4.82B | 5.32B | 4.79B | 3.91B | |||
| Non Interest Income | 2.48B | 2.27B | 2.26B | 2.43B | 2.52B | |||
| Loan Loss Provision | 475.00M | 487.00M | 553.00M | 271.00M | -524.00M | |||
| Net Interest Income after Provision | 4.46B | 4.33B | 4.77B | 4.51B | 4.44B | |||
| Non Interest Expense | -4.25B | -4.24B | -4.42B | -4.07B | -3.75B | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 2.69B | 2.35B | 2.61B | 2.88B | 3.21B | |||
| Income Tax | 536.00M | 461.00M | 533.00M | 631.00M | 694.00M | |||
| Net Income | 2.06B | 1.77B | 1.98B | 2.15B | 2.40B | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.2725000000000004 | 1.9325 | 2.1066 | 2.2781 | 2.49 | |||
| Non GAAP EPS | 2.27 | 2.01 | 2.19 | 2.3600000000000003 | 2.48 | |||
| Statistics | ||||||||
| Profit Margin | 27.70% | 25.05% | 26.08% | 29.74% | 37.28% | |||
All data in USD